ORIGINAL ARTICLE
Downregulated lncRNA LINC00908 correlates with a poor prognosis and increasing malignancy of gastric cancer
More details
Hide details
1
Department of Oncology, Hengshui People’s Hospital, Hengshui, China
2
Department of Neurosurgery, Hengshui People’s Hospital, Hengshui, China
Submission date: 2023-10-26
Acceptance date: 2024-04-07
Publication date: 2024-07-09
Corresponding author
Chunyue Zhang
Department of Oncology, Hengshui People’s Hospital, Hengshui 053000, China
Pol J Pathol 2024;75(2):157-165
KEYWORDS
TOPICS
ABSTRACT
Long non-coding RNA LINC00908 is a functional biomarker in regulating tumour progression. Its dysregulation in gastric cancer implies its potential functional role. Few studies have noted the functional role of LINC00908 in gastric cancer. The potential of LINC00908 to serve as a biomarker in gastric cancer was evaluated.
A total of 113 paired gastric cancer tissues and normal tissues were collected from patients with gastric cancer. LINC00908 levels were evaluated by polymerase chain reaction, and its significance in disease progression and patients’ prognosis was assessed.
In vitro, the function of LINC00908 in tumour-related cellular processes was evaluated with CCK8 and Transwell assay. Significant downregulation of LINC00908 was observed in gastric cancer and was negatively associated with disease development and overall survival of patients. LINC00908 showed significant inhibitory effects on the proliferation, migration, and invasion of gastric cancer cells.
Additionally, miR-627-3p was sponged by LINC00908 and therefore mediated the function of LINC00908 in gastric cancer cells. LINC00908 functioned as a prognostic biomarker and tumour suppressor of gastric cancer, providing a therapeutic target for gastric cancer.
REFERENCES (30)
1.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin 2020; 70: 7-30.
2.
Chen Z, Li Y, Tan B, Zhao Q, Fan L, Li F, Zhao X. Progress and current status of molecule-targeted therapy and drug resistance in gastric cancer. Drugs Today (Barc) 2020; 56: 469-482.
3.
Youn GJ, Chung WC. Micrometastasis in gastric cancer. Korean J Gastroenterol 2017; 69: 270-277.
4.
Zhao JZ, Zhang RP, Wang G, Li FX, Wang XJ, Xue Q, Liang H. Prognosis of patients with recurrence after curative resection of advanced gastric cancer. Zhonghua Wei Chang Wai Ke Za Zhi 2011; 14: 107-110.
5.
Esteller M, Pandolfi PP. The epitranscriptome of noncoding RNAs in cancer. Cancer Discov 2017; 7: 359-368.
6.
Jain S, Thakkar N, Chhatai J, Pal Bhadra M, Bhadra U. Long non-coding RNA: functional agent for disease traits. RNA Biol 2017; 14: 522-535.
7.
Necsulea A, Soumillon M, Warnefors M, et al. The evolution of lncRNA repertoires and expression patterns in tetrapods. Nature 2014; 505: 635-640.
8.
Huang Y, Zhang J, Hou L, et al. LncRNA AK023391 promotes tumorigenesis and invasion of gastric cancer through activation of the PI3K/Akt signaling pathway. J Exp Clin Cancer Res CR 2017; 36: 194.
9.
Wei GH, Wang X. lncRNA MEG3 inhibit proliferation and metastasis of gastric cancer via p53 signaling pathway. Eur Rev Med Pharmacol Sci 2017; 21: 3850-3856.
10.
Xu MD, Wang Y, Weng W, et al. A positive feedback loop of lncRNA-PVT1 and FOXM1 facilitates gastric cancer growth and invasion. Clin Cancer Res 2017; 23: 2071-2080.
11.
Zhang L, Kang W, Lu X, Ma S, Dong L, Zou B. LncRNA CASC11 promoted gastric cancer cell proliferation, migration and invasion in vitro by regulating cell cycle pathway. Cell Cycle (Georgetown, Tex) 2018; 17: 1886-1900.
12.
Fan L, Li H, Zhang Y. LINC00908 negatively regulates microRNA-483-5p to increase TSPYL5 expression and inhibit the development of prostate cancer. Cancer Cell Int 2020; 20: 10.
13.
Miao Y, Sui J, Xu SY, Liang GY, Pu YP, Yin LH. Comprehensive analysis of a novel four-lncRNA signature as a prognostic biomarker for human gastric cancer. Oncotarget 2017; 8: 75007-75024.
14.
He M, Shen P, Qiu C, Wang J. miR-627-3p inhibits osteosarcoma cell proliferation and metastasis by targeting PTN. Aging (Albany NY) 2019; 11: 5744-5756.
15.
Wang Z, Cao Z, Wang Z. Significance of long non-coding RNA IFNG-AS1 in the progression and clinical prognosis in colon adenocarcinoma. Bioengineered 2021; 12: 11342-11350.
16.
Zhuang H, Ma X, Liu X, et al. Hyaluronan-mediated motility receptor antisense RNA 1 promotes hepatitis B virus-related hepatocellular carcinoma progression by regulating miR-627-3p/High Mobility Group AT-hook 2 axis. Bioengineered 2022; 13: 8617-8630.
17.
Solsky I, In H. Surgical treatment for gastric cancer. Gastrointest Endosc Clin N Am 2021; 31: 581-605.
18.
Tan Z. Recent advances in the surgical treatment of advanced gastric cancer: a review. Med Sci Monit 2019; 25: 3537-3541.
19.
Digklia A, Wagner AD. Advanced gastric cancer: current treatment landscape and future perspectives. World J Gastroenterol 2016; 22: 2403-2414.
20.
Li J, Meng H, Bai Y, Wang K. Regulation of lncRNA and its role in cancer metastasis. Oncol Res 2016; 23: 205-217.
21.
Schmitt AM, Chang HY. Long noncoding RNAs in cancer pathways. Cancer Cell 2016; 29: 452-463.
22.
Liang Y, Song X, Li Y, et al. LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis. Mol Cancer 2020; 19: 85.
23.
Shuai Y, Ma Z, Liu W, et al. TEAD4 modulated LncRNA MNX1-AS1 contributes to gastric cancer progression partly through suppressing BTG2 and activating BCL2. Mol Cancer 2020; 19: 6.
24.
Hu X, Li Q, Zhang J. The long noncoding RNA LINC00908 facilitates hepatocellular carcinoma progression via interaction with Sox-4. Cancer Manag Res 2019; 11: 8789-8797.
25.
Shen XQ, Wu QM, Yang CH, Yan QD, Cao PJ, Chen FL. Four low expression lncRNAs are associated with prognosis of human lung adenocarcinoma. Clin Lab 2020; 66.
26.
Sheng Y, Han C, Yang Y, et al. Correlation between lncRNA-LINC00659 and clinical prognosis in gastric cancer and study on its biological mechanism. J Cell Mol Med 2020; 24: 14467-14480.
27.
Song L, Zhang S, Duan C, et al. Genome-wide identification of lncRNAs as novel prognosis biomarkers of glioma. J Cell Biochem 2019; 120: 19518-19528.
28.
Shan TD, Tian ZB, Li Q, et al. Long intergenic noncoding RNA 00908 promotes proliferation and inhibits apoptosis of colorectal cancer cells by regulating KLF5 expression. J Cell Physiol 2021; 236: 889-899.
29.
Shin VY, Ng EK, Chan VW, Kwong A, Chu KM. A three-miRNA signature as promising non-invasive diagnostic marker for gastric cancer. Mol Cancer 2015; 14: 202.
30.
Raad M, Salehi Z, Habibzaadeh Baalsini M, Mashayekhi F, Saeidi Saedi H. Association of rs2620381 polymorphism in miR-627 and gastric cancer. Br J Biomed Sci 2020; 77: 76-80.